Ranganatha R. Somasagara

916 total citations · 1 hit paper
15 papers, 731 citations indexed

About

Ranganatha R. Somasagara is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Ranganatha R. Somasagara has authored 15 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Ranganatha R. Somasagara's work include DNA Repair Mechanisms (4 papers), Cancer-related Molecular Pathways (3 papers) and CAR-T cell therapy research (2 papers). Ranganatha R. Somasagara is often cited by papers focused on DNA Repair Mechanisms (4 papers), Cancer-related Molecular Pathways (3 papers) and CAR-T cell therapy research (2 papers). Ranganatha R. Somasagara collaborates with scholars based in United States, India and Israel. Ranganatha R. Somasagara's co-authors include Bibha Choudhary, Sathees C. Raghavan, Mahesh Hegde, Shikha Srivastava, Satish K. Tadi, Mrinal Srivastava, Mayilaadumveettil Nishana, Kishore K. Chiruvella, Kaushlendra Tripathi and Komaraiah Palle and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Ranganatha R. Somasagara

14 papers receiving 717 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quercetin, a Natural Flavonoid Interacts with DNA, Arrests Cell Cycle and Causes Tumor Regression by Activating Mitochondrial Pathway of Apoptosis

2016 393 citations Shikha Srivastava, Ranganatha R. Somasagara et al. Scientific Reports profile →

Peers

Countries citing papers authored by Ranganatha R. Somasagara

Since Specialization

Citations

This map shows the geographic impact of Ranganatha R. Somasagara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranganatha R. Somasagara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranganatha R. Somasagara more than expected).

Fields of papers citing papers by Ranganatha R. Somasagara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranganatha R. Somasagara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranganatha R. Somasagara. The network helps show where Ranganatha R. Somasagara may publish in the future.

Co-authorship network of co-authors of Ranganatha R. Somasagara

This figure shows the co-authorship network connecting the top 25 collaborators of Ranganatha R. Somasagara. A scholar is included among the top collaborators of Ranganatha R. Somasagara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranganatha R. Somasagara. Ranganatha R. Somasagara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Large-Scale Non-Viral Genetic Modification and Feeder-Free Production of CAR-NK Cells 2025 ·Cytotherapy ·Dhiraj Kumar, Orna Cohen, S. Lee, Ranganatha R. Somasagara, (unknown), Aravind Chandrasekaran, (unknown)	1
2	Advancing Allogenic Cell Therapy with Automated iPSC Processing and Engineering: Benefits of a Closed Modular Approach. 2025 ·Cytotherapy ·Ranganatha R. Somasagara, Ofer Cohen, Youngsoo Kim, (unknown), (unknown), Vivek Chandra, (unknown), Aravind Chandrasekaran, Namritha Ravinder	0
3	Zebrafish Xenograft Model to Study Human Cancer 2022 ·Methods in molecular biology ·Ranganatha R. Somasagara, TinChung Leung	4
4	Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition. 2021 ·Neoplasia ·Chinnadurai Mani, Kaushlendra Tripathi, Sandeep Chaudhary, Ranganatha R. Somasagara, Rodney P. Rocconi, Chiquito Crasto, Mark B. Reedy, Mohammad Athar, Komaraiah Palle	10
5	Targeted therapy of human leukemia xenografts in immunodeficient zebrafish 2021 ·Scientific Reports ·Ranganatha R. Somasagara, Xiaoyan Huang, Chunyu Xu, Jamil Haider, Jonathan S. Serody, Paul M. Armistead, TinChung Leung	20
6	RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance 2017 ·Oncogene ·Ranganatha R. Somasagara, (unknown), Kaushlendra Tripathi, David W. Clark, Chinnadurai Mani, Luciana Madeira da Silva, Jennifer Scalici, Hend Kothayer, Andrew D. Westwell, Rodney P. Rocconi, Komaraiah Palle	54
7	Targeting MYC Dependence by Metabolic Inhibitors in Cancer 2017 ·Genes ·Himalee S. Sabnis, Ranganatha R. Somasagara, Kevin D. Bunting	28
8	Detection and evaluation of estrogen DNA‐adducts and their carcinogenic effects in cultured human cells using biotinylated estradiol 2016 ·Molecular Carcinogenesis ·Kaushlendra Tripathi, Chinnadurai Mani, Ranganatha R. Somasagara, David W. Clark, Venkateshwari Ananthapur, K. Vinaya, Komaraiah Palle	15
9	Extract of Vernonia condensata, Inhibits Tumor Progression and Improves Survival of Tumor-allograft Bearing Mouse 2016 ·Scientific Reports ·Elizabeth Thomas, Vidya Gopalakrishnan, Ranganatha R. Somasagara, Bibha Choudhary, Sathees C. Raghavan	46
10	Quercetin, a Natural Flavonoid Interacts with DNA, Arrests Cell Cycle and Causes Tumor Regression by Activating Mitochondrial Pathway of Apoptosis breakdown → 2016 ·Scientific Reports ·Shikha Srivastava, Ranganatha R. Somasagara, Mahesh Hegde, Mayilaadumveettil Nishana, Satish K. Tadi, Mrinal Srivastava, Bibha Choudhary, Sathees C. Raghavan	393
11	Rad6 inhibition sensitizes ovarian cancer cells to platinum drugs by attenuating activation of multiple DNA repair networks 2016 ·Gynecologic Oncology ·(unknown), Ranganatha R. Somasagara, Kaushlendra Tripathi, Lavanya Bachaboina, Jennifer Scalici, Rodney P. Rocconi, Komaraiah Palle	1
12	Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells 2015 ·International Journal of Oncology ·Ranganatha R. Somasagara, (unknown), Sangeeta Shrotriya, Manisha Patel, Chapla Agarwal, Rajesh Agarwal	25
13	Rad6 upregulation promotes stem cell-like characteristics and platinum resistance in ovarian cancer 2015 ·Biochemical and Biophysical Research Communications ·Ranganatha R. Somasagara, Kaushlendra Tripathi, (unknown), David W. Clark, (unknown), Lavanya Bachaboina, Jennifer Scalici, Rodney P. Rocconi, Gary A. Piazza, Komaraiah Palle	19
14	Target Identification of Grape Seed Extract in Colorectal Cancer Using Drug Affinity Responsive Target Stability (DARTS) Technique: Role of Endoplasmic Reticulum Stress Response Proteins 2014 ·Current Cancer Drug Targets ·(unknown), Ranganatha R. Somasagara, Komal Raina, Sushil Kumar, Joe Gomez, Manisha Patel, Rajesh Agarwal, Chapla Agarwal	32
15	Extracts of Strawberry Fruits Induce Intrinsic Pathway of Apoptosis in Breast Cancer Cells and Inhibits Tumor Progression in Mice 2012 ·PLoS ONE ·Ranganatha R. Somasagara, Mahesh Hegde, Kishore K. Chiruvella, (unknown), Bibha Choudhary, Sathees C. Raghavan	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact